2019 Annual Meeting | N3 - Neuroscience in the Clinic: Stem Cells
Program Materials Program Evaluations
01:00 PM - 01:05 PM EDT | Introduction |
Introduction
Paul M. George, MD, PhD, MSE, FAAN |
01:05 PM - 01:15 PM EDT | Speaker |
Clinical Cases
Paul M. George, MD, PhD, MSE, FAAN |
01:15 PM - 01:40 PM EDT | Speaker |
The Basic Science of Stem Cells
Sean I. Savitz, MD |
01:40 PM - 01:50 PM EDT | Speaker |
Current State of Stem Cells in Neurology
Paul M. George, MD, PhD, MSE, FAAN |
01:50 PM - 02:00 PM EDT | Speaker |
Perils of Stem Cell Tourism
Jaime Imitola, MD, FAAN |
02:00 PM - 02:15 PM EDT | Abstract |
001 - Peripheral Nerve Grafting as a Disease Modifying Cell Therapy for Parkinson’s Disease
Nader El Seblani, MD, PhD |
02:15 PM - 02:30 PM EDT | Abstract |
002 - Phase I/II Clinical Trials Testing Multiple Dosing of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Patients with Progressive MS
Saud Sadiq, BS, FAAN |
02:30 PM - 03:00 PM EDT | Q&A |
Panel Discussion
Paul M. George, MD, PhD, MSE, FAAN, Antonio M. Omuro, MD, FAAN |
Paul M. George, MD, PhD, MSE, FAAN | Dr. George has received personal compensation in the range of $0-$499 for serving as a Consultant for ConductiveBio. Dr. George has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law firms. The institution of Dr. George has received research support from Conductive Bio. The institution of Dr. George has received research support from NIH. Dr. George has received intellectual property interests from a discovery or technology relating to health care. Dr. George has received personal compensation in the range of $5,000-$9,999 for serving as a Adjudicator with Baim Insititute. Dr. George has a non-compensated relationship as a Board Member with 好色先生 that is relevant to AAN interests or activities. |
Antonio M. Omuro, MD, FAAN | Dr. Omuro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as a Consultant for Kiyatec. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pyramid. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curevac. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Opinion in Neurology. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Agios. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Denovo Biopharma. |
Sean I. Savitz, MD | Dr. Savitz has nothing to disclose. |
Jaime Imitola, MD, FAAN | The institution of Dr. Imitola has received research support from Genentech. Dr. Imitola has a non-compensated relationship as a Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Imitola has a non-compensated relationship as a Committee Member with International Society for Stem Cell Research that is relevant to AAN interests or activities. |
No disclosure on file | |
Andrew Welleford, MD, PhD | Dr. Welleford has nothing to disclose. |
Nader El Seblani, MD, PhD | Dr. El Seblani has nothing to disclose. |
Sophia Yang, MD | No disclosure on file |
Beth Levine | No disclosure on file |
Saud Sadiq, BS, FAAN | Ms. Brewi has nothing to disclose. |
Violaine K. Harris, PhD | No disclosure on file |
James Stark, MD, FAAN | Dr. Stark has nothing to disclose. |